









市場行情
/
股票
/
nasdaq-txg
/

10X Genomics Inc

TXG

20.460USD

+1.170+6.07%

收盤 01/09, 16:00（美東）報價延遲15分鐘

2.59B總市值

虧損本益比TTM



10X Genomics Inc

20.460

+1.170+6.07%

概覽公司財務分析

概覽

公司

財務

分析

關於 10X Genomics Inc 公司

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.

10X Genomics Inc簡介



公司代碼TXG

公司名稱10X Genomics Inc

上市日期Sep 12, 2019

CEOSaxonov (Serge Wilson)

員工數量1306

證券類型Ordinary Share

年結日Sep 12

公司地址6230 Stoneridge Mall Road

城市PLEASANTON

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編94588

電話19254017300

網址https://www.10xgenomics.com/

公司代碼TXG

上市日期Sep 12, 2019

CEOSaxonov (Serge Wilson)

10X Genomics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.04M

-13261.00%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+15357.00%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+45563.00%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+15357.00%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

36.41K

-8283.00%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+15357.00%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+15357.00%

Mr. Alan V. Mateo

Independent Director

Dr. Sarah A. Teichmann

Independent Director

Mr. Adam S. Taich

Chief Financial Officer

名稱

名稱/職務

職務

持股

持股變動

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.04M

-13261.00%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+15357.00%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+45563.00%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+15357.00%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

36.41K

-8283.00%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+15357.00%

收入明細

單位: USD更新時間: 1月6日週二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Consumables

127.89M

85.83%

Instruments

12.00M

8.05%

Services

8.13M

5.45%

License and royalty revenue

983.00K

0.66%

地區USD

名稱

營收

佔比

United States

77.25M

51.84%

Europe, the Middle East and Africa

41.62M

27.94%

China

15.19M

10.19%

Asia Pacific

12.32M

8.27%

Americas

2.63M

1.76%

業務

地區

業務USD

名稱

營收

佔比

Consumables

127.89M

85.83%

Instruments

12.00M

8.05%

Services

8.13M

5.45%

License and royalty revenue

983.00K

0.66%

股東統計

更新時間: 11月19日週三

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

11.38%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Millennium Management LLC

4.67%

其他

60.88%

持股股東

佔比

The Vanguard Group, Inc.

11.38%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Millennium Management LLC

4.67%

其他

60.88%

股東類型

持股股東

佔比

Investment Advisor

52.34%

Investment Advisor/Hedge Fund

27.24%

Hedge Fund

14.51%

Research Firm

6.24%

Bank and Trust

5.01%

Venture Capital

1.88%

Individual Investor

1.80%

Family Office

0.84%

Pension Fund

0.54%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

684

126.11M

108.27%

-15.61M

2025Q3

675

117.21M

102.45%

-24.61M

2025Q2

669

120.42M

108.39%

-15.20M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

13.25M

11.38%

+834.27K

+6.72%

Sep 30, 2025

ARK Investment Management LLC

11.89M

10.21%

-2.00M

-14.43%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

7.78M

6.68%

+194.98K

+2.57%

Sep 30, 2025

Fidelity Management & Research Company LLC

7.21M

6.19%

-430.91K

-5.64%

Sep 30, 2025

Millennium Management LLC

5.44M

4.67%

+2.55M

+88.57%

Sep 30, 2025

Sumitomo Mitsui Trust Bank, Limited

5.38M

4.62%

-636.74K

-10.58%

Sep 30, 2025

Amova Asset Management Co., Ltd.

5.38M

4.62%

+5.38M

Sep 30, 2025

Wellington Management Company, LLP

4.29M

3.68%

+2.39M

+126.60%

Sep 30, 2025

Quantinno Capital Management LP

3.49M

+1.26M

+56.37%

Sep 30, 2025

BofA Global Research (US)

3.30M

2.83%

+393.85K

+13.55%

Sep 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

ARK Genomic Revolution ETF

4.02%

Simplify Health Care ETF

2.89%

Janus Henderson Small Cap Growth Alpha ETF

1.66%

Global X Genomics & Biotechnology ETF

1.56%

ARK Innovation ETF

1.3%

WisdomTree BioRevolution Fund

1.28%

Janus Henderson Small/Mid Cap Growth Alpha ETF

1.17%

Harbor Long-Short Equity ETF

0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.53%

Invesco NASDAQ Future Gen 200 ETF

0.52%

ARK Genomic Revolution ETF

佔比4.02%

Simplify Health Care ETF

佔比2.89%

Janus Henderson Small Cap Growth Alpha ETF

佔比1.66%

Global X Genomics & Biotechnology ETF

佔比1.56%

ARK Innovation ETF

佔比1.3%

WisdomTree BioRevolution Fund

佔比1.28%

Janus Henderson Small/Mid Cap Growth Alpha ETF

佔比1.17%

Harbor Long-Short Equity ETF

佔比0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.53%

Invesco NASDAQ Future Gen 200 ETF

佔比0.52%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

10X Genomics Inc的前五大股東是誰？



10X Genomics Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：13.25M
佔總股份比例：11.38%。
ARK Investment Management LLC
持有股份：11.89M
佔總股份比例：10.21%。
BlackRock Institutional Trust Company, N.A.
持有股份：7.78M
佔總股份比例：6.68%。
Fidelity Management & Research Company LLC
持有股份：7.21M
佔總股份比例：6.19%。
Millennium Management LLC
持有股份：5.44M
佔總股份比例：4.67%。